Sildenafil Tablet, Film Coated
Product Images NDC 68071-3745

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-3745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3745 6)

Sildenafil 50 mg film-coated tablets packaging label from NuCare Pharmaceuticals, Inc. The label shows a bottle containing 60 tablets. It notes the tablet is diamond-shaped, white to off-white, biconvex, with 'T' and '29' debossed on opposite sides. The label includes NDC 68071-3745-6, manufacturing details from Aurobindo Pharma Limited India, and storage instructions at controlled temperature 68-77°F.*

FDA Label Image

Figure 1 (Sildenafil Fig1)

A line graph showing mean change from baseline in sitting systolic blood pressure over 24 hours post-dose. It compares Sildenafil 100 mg and placebo in healthy volunteers, with systolic blood pressure (mmHg) on the y-axis and time post-dose (hours) on the x-axis. The graph depicts fluctuations for both treatments, illustrating trends in blood pressure changes over time.*

FDA Label Image

Figure 2 (Sildenafil Fig2)

A line graph illustrating mean standing systolic blood pressure change from baseline over time postdose in hours. It compares two groups: Doxazosin with placebo and Doxazosin with Sildenafil 25 mg. The vertical axis shows change in systolic blood pressure (mmHg), and the horizontal axis shows time postdose (hours).*

FDA Label Image

Figure 3 (Sildenafil Fig3)

Line graph showing mean standing systolic blood pressure change (in mmHg) over time postdose (hours) for two groups: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg. The x-axis represents time from 0 to 8 hours postdose, and the y-axis shows change in systolic blood pressure ranging from -50 to 40 mmHg. The graph compares blood pressure changes from baseline between the two treatments.*

FDA Label Image

Figure 4 (Sildenafil Fig4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing changes in mmHg over time (hours) after dosing up to 8 hours. It compares two groups: Doxazosin + Sildenafil 100 mg and Doxazosin + Placebo, with systolic blood pressure changes plotted on the vertical axis and time after dosing on the horizontal axis.*

FDA Label Image

Figure 5 (Sildenafil Fig5)

A line graph titled 'Figure 5: Mean Sildenafil Plasma Concentrations in Healthy Male Volunteers' showing plasma concentrations (ng/mL) of sildenafil over time post dose (hours). The plot depicts concentration peaking sharply around 1 hour after dosing and gradually declining to near zero by 24 hours, representing data for a commercial sildenafil tablet.*

FDA Label Image

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)

Two bar charts titled 'Effect of Sildenafil on Maintenance of Erection by Baseline Score' and 'Effect of Placebo on Maintenance of Erection by Baseline Score' showing the percentage of patients at endpoint across baseline scores 0 to 5. Each baseline score category includes bars representing scores from 0 to 5 in a legend. The graphs compare the maintenance of erection between Sildenafil and placebo treatments.*

FDA Label Image

Sildenafile Fig 7 (Sildenafil Fig7)

A bar graph showing the percentage of patients reporting an improvement in erections across four treatment groups: Placebo, Sildenafil 25 mg, Sildenafil 50 mg, and Sildenafil 100 mg. The graph illustrates increasing percentages of patient improvement with higher Sildenafil doses compared to placebo.*

FDA Label Image

Structure (Sildenafil Str)

Chemical structure diagram showing the molecular composition of Sildenafil. The structure includes distinct rings, functional groups such as sulfonyl, amide, and carboxyl groups, representing the chemical arrangement of the active ingredient Sildenafil.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.